Pathway nets another patent for atherectomy system

TriMed Staff | | Health Imaging | Diagnostic Imaging
Pathway Medical Technologies, a provider of endovascular treatments for peripheral arterial disease (PAD), was recently granted another patent for its Pathway PV atherectomy system.

The issuance of this latest patent enhances the intellectual property related to Pathway’s atherectomy system, which is designed to treat the arterial disease found in the legs, according to the company.

The Kirkland, Wash.-based Pathway has a total of three patents issued by the U.S. patent office relating to differential cutting and the removal of atherosclerotic plaque for its rotational atherectomy system with several other patents pending.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.